Crossmark

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial

Crossref DOI link: https://doi.org/10.1186/s13613-019-0536-5

Published Print: 2019

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ham, Kealy R.

Boldt, David W.

McCurdy, Michael T.

Busse, Laurence W.

Favory, Raphael

Gong, Michelle N.

Khanna, Ashish K.

Chock, Stefan N.

Zeng, Feng

Chawla, Lakhmir S.

Tidmarsh, George F.

Ostermann, Marlies
License Information

Text and Data Mining valid from 2019-01-01

Text and Data Mining valid from 2019-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-019-0536-5

Content Type: article

Copyright: Copyright © 2019 The Author(s) 2019. Published by Elsevier Masson SAS